Skip to main content
Log in

Study of the Pressing Process of N-Butyl-N-Methyl-1-Phenylpyrrolo-[1,2-a]Pyrazine-3-Carboxamide (GML-3) Tablets Using Mathematical Modeling Techniques

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

N-Butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide (GML-3) is an original molecule developed at the Research Zakusov Institute of Pharmacology. GML-3 has both anxiolytic and antidepressant activity, which makes the development of tablets based on it a promising task. Optimization of the pressing process is currently an urgent task of the pharmaceutical industry because this technological stage has a significant impact on the disintegration of tablets and the release of the active pharmaceutical ingredient. The Heckel and Kuenz–Leuenberger models were used to study the pressing process of GML-3 tablets. These models were compared to select the most reliable description of pressing GML-3 tablets from granules. Granules with polyvinylpyrrolidone (PVP) and hydroxypropylmethylcellulose (HPMC) as a binder were used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. S. V. Tishkov, E. V. Blynskaya, K. V. Alekseev, et al., Khim.-farm. Zh., 55(12), 38 – 42 (2021).

    Google Scholar 

  2. D. Lamesic, O. Planinsek, and I. Ilic, Eur. J. Pharm. Sci., 121(1), 218 – 227 (2018).

    Article  CAS  PubMed  Google Scholar 

  3. M. Leane, K. Pitt, and G. Reynolds, Pharm. Dev. Technol., 23(10), 964 – 977 (2018).

    Article  CAS  PubMed  Google Scholar 

  4. E. V. Blynskaya, B. V. Markeev, K. V. Alekseev, et al., Khim.-farm. Zh., 55(6), 34 – 46 (2021).

    Google Scholar 

  5. T. Stirnimann, S. Atria, J. Schoelkop, et al., Int. J. Pharm., 466(1–2), 266 – 275 (2014).

    Article  CAS  PubMed  Google Scholar 

  6. F. Osei-Yeboah, S.-Y. Chang, and C. C. Sun, Pharm. Res., 33(1), 1126 – 1132 (2016). S. Paul and C. C. Sun, Eur. J. Pharm. Sci., 117, 118 – 127 (2018).

Download references

Acknowledgments

We thank Dr. K. V. Alekseev for advice and valuable comments in preparing the article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. B. Markeev.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 12, pp. 43 – 48, December, 2023

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markeev, V.B., Tishkov, S.V., Blynskaya, E.V. et al. Study of the Pressing Process of N-Butyl-N-Methyl-1-Phenylpyrrolo-[1,2-a]Pyrazine-3-Carboxamide (GML-3) Tablets Using Mathematical Modeling Techniques. Pharm Chem J 57, 1998–2003 (2024). https://doi.org/10.1007/s11094-024-03107-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-024-03107-z

Keywords

Navigation